These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Comments on the contribution by M. Vogt et al. New developments and prospects in antiviral chemotherapy]. Rieckemann B; Ranneberg B Internist (Berl); 1993 Feb; 34(2):190. PubMed ID: 8384189 [No Abstract] [Full Text] [Related]
25. [The principles of the pathogenetic antiherpetic chemotherapy of acute and recurrent herpesvirus infections]. Khakhalin LN; Abazova FI Ter Arkh; 1995; 67(1):55-9. PubMed ID: 7709360 [No Abstract] [Full Text] [Related]
26. Successful secondary prophylaxis for primary effusion lymphoma with human herpesvirus 8 therapy. Crum-Cianflone NF; Wallace MR; Looney D AIDS; 2006 Jul; 20(11):1567-9. PubMed ID: 16847420 [No Abstract] [Full Text] [Related]
28. Antiviral drug development: the road less taken. Balfour HH Ann Pharmacother; 1996 Sep; 30(9):964-6. PubMed ID: 8876857 [No Abstract] [Full Text] [Related]
29. Antiviral therapy in the immunocompromised patient. Prentice HG; Hann IM Br Med Bull; 1985 Oct; 41(4):367-73. PubMed ID: 2996686 [No Abstract] [Full Text] [Related]
30. [Clinical evaluation of the efficacy of Tebrofen in viral infections of the eye]. Kulikova LA Oftalmol Zh; 1971; 26(5):375-8. PubMed ID: 4332806 [No Abstract] [Full Text] [Related]
31. Antivirals against DNA viruses (hepatitis B and the herpes viruses). Hewlett G; Hallenberger S; Rübsamen-Waigmann H Curr Opin Pharmacol; 2004 Oct; 4(5):453-64. PubMed ID: 15351349 [TBL] [Abstract][Full Text] [Related]
32. Valacyclovir for the management of herpes viral infections. Chakrabarty A; Anderson NJ; Beutner R; Tyring SK Skin Therapy Lett; 2005 Feb; 10(1):1-4. PubMed ID: 15776202 [TBL] [Abstract][Full Text] [Related]
33. Herpes virus infections, HIV, and disease progression. Wait and see. Japour A AIDS Clin Care; 1995 Feb; 7(2):15, 18. PubMed ID: 12212540 [No Abstract] [Full Text] [Related]
34. Prevention and treatment of neonatal herpes. Brunell PA Pediatrics; 1980 Nov; 66(5):806-8. PubMed ID: 6253869 [No Abstract] [Full Text] [Related]
35. [Viruses and antiviral drug resistance]. Hovi T; Järvinen A; Pyhälä R; Ristola M; Salminen M Duodecim; 2002; 118(9):911-8. PubMed ID: 12238169 [No Abstract] [Full Text] [Related]
36. Antiviral drugs in the immunocompetent host: part I. Treatment of hepatitis, cytomegalovirus, and herpes infections. Colgan R; Michocki R; Greisman L; Moore TA Am Fam Physician; 2003 Feb; 67(4):757-62, 675. PubMed ID: 12613729 [TBL] [Abstract][Full Text] [Related]
37. Human herpes virus-6 encephalitis in a paediatric bone marrow recipient: successful treatment with pharmacokinetic monitoring and high doses of ganciclovir. Janoly-Duménil A; Galambrun C; Basset T; Mialou V; Bertrand Y; Bleyzac N Bone Marrow Transplant; 2006 Dec; 38(11):769-70. PubMed ID: 17013421 [No Abstract] [Full Text] [Related]
39. The effect of some antiviral drugs on the cell metabolism in the eye. Maichuk YF; Kasavina BS Metab Pediatr Ophthalmol; 1980; 4(2):79-82. PubMed ID: 6255265 [No Abstract] [Full Text] [Related]
40. Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease. Razonable RR; Brown RA; Humar A; Covington E; Alecock E; Paya CV; J Infect Dis; 2005 Oct; 192(8):1331-9. PubMed ID: 16170749 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]